Eckert & Ziegler Strahlen- und Medizintechnik AG Stock – Fundamental Analysis
Fundamental Data & Ratios (Balance sheet update: 4/2/2026)
| Balance Sheet | Total Assets | 485,676,000.00 | ROE | 51.84 % |
| Balance Sheet | Total Equity | 251,767,000.00 | ROA | 10.04 % |
| Cashflow | Capital Expenditures | -26,020,000.00 | P/FCF | 22.46 |
| Cashflow | Free Cash Flow | 34,386,000.00 | – | – |
| Cashflow | Operating Cash Flow | 60,406,000.00 | P/CF | 12.79 |
| Income | Earnings per Share (diluted) | 0.78 | Div. Yield | – |
| Income | Net Income | 48,763,000.00 | P/E | 15.77 |
| Income | Shares Outstanding | 62,797,000.00 | P/B | 3.07 |
| Income | Total Revenue | 311,960,000.00 | P/S | 2.48 |
Ratios calculated on: 10/14/2026
Company Description
Eckert & Ziegler Strahlen- und Medizintechnik AG, through its subsidiaries, provides isotope technology components for medical, scientific, and industrial use worldwide. It operates through three segments: Radiation Therapy, Radiopharma, and Isotope Products. The Radiation Therapy segment develops, manufactures, markets, and sells radioactive products for cancer therapy. This segment offers small radioactive implants for the treatment of prostate cancer seeds; and tumor radiation devices and eye applicators. This segment\'s products and equipment are used by oncologists, radiotherapists, urologists, ophthalmologists, and medical physicists. The Radiopharma segment operates in the field of molecular imaging and nuclear medicine; and supplies various radiopharmaceuticals, radiochemicals, and related equipment for the synthesis and radiochromatography of PET/SPECT tracers and other radioisotopes. This segment provides products in the categories of radiosynthesis technology, radiochromatography, and radionuclides. The Isotope Products segment offers sealed and unsealed radiation sources for medical imaging, industrial gauging, measurement and analysis, reference, calibration, and environmental monitoring sources and solutions; and bulk radioisotopes for pharmaceutical, therapeutic, and industrial product manufacturers. It also provides custom and one-off design and manufacturing services. In addition, the company offers services for collection, recycling, and disposal of sealed radioactive sources and low activity isotope related waste from hospitals, research institutes, and industries. Eckert & Ziegler Strahlen- und Medizintechnik AG was founded in 1992 and is headquartered in Berlin, Germany.
Additional comparison and history views are available after login.
Finanzoo GmbH assumes no liability for the accuracy of the information provided! All information is provided without guarantee. Sources: www.bundesanzeiger.de, www.sec.gov, www.ezag.de
All metrics and scores are an automated evaluation and not investment advice or a recommendation to buy or sell. Finanzoo GmbH or its shareholders may themselves hold positions in the securities shown.
Learn more